Olmo Camara-Martin
Madrid, MD 28040, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Targeting toll-like receptors in the immunotherapy era: the chemistry behind TLR modulators.
Journal: Chemical Society reviews
Published: August 18, 2026
Resveratrol modulates pancreatic proteotoxic stress and metabolic dysfunction in human IAPP transgenic mice.
Journal: Frontiers in endocrinology
Published: May 03, 2026
Validating Natural Compounds as Toll-Like Receptor 4 (TLR4) Antagonists: Experimental Challenges and Therapeutic Perspectives.
Journal: Journal of medicinal chemistry
Published: December 19, 2025
m-Terphenylamines, Acting as Selective COX-1 Inhibitors, Block Microglia Inflammatory Response and Exert Neuroprotective Activity.
Journal: Molecules (Basel, Switzerland)
Published: June 14, 2023
Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis.
Journal: Journal of medicinal chemistry
Published: January 05, 2022
Curcumin-Piperlongumine Hybrids with a Multitarget Profile Elicit Neuroprotection in In Vitro Models of Oxidative Stress and Hyperphosphorylation.
Journal: Antioxidants (Basel, Switzerland)
Published: November 21, 2021
Bifunctional carbazole derivatives for simultaneous therapy and fluorescence imaging in prion disease murine cell models.
Journal: European journal of medicinal chemistry
Published: November 03, 2021
Emerging targets in drug discovery against neurodegenerative diseases: Control of synapsis disfunction by the RhoA/ROCK pathway.
Journal: European journal of medicinal chemistry
Published: September 17, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026